Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

C4 Therapeutics (CCCC) Tax Rate (2019 - 2024)

C4 Therapeutics' quarterly Tax Rate came in at 0.38% in Q4 2024, up 43.0% year-on-year from 0.27% in Q1 2024, and up 53.17% quarter-over-quarter from 0.81% in Q4 2023.

C4 Therapeutics has reported Tax Rate for 4 years, with the latest figure at 0.38% in Q4 2024.

  • For the quarter ending Q4 2024, Tax Rate rose 43.0% year-over-year to 0.38%; the trailing twelve-month figure through Dec 2024 stood at 0.12% (up 85.0% YoY), and the FY2025 full-year result was 0.12%, up 1.0% from the prior year.
  • Tax Rate for Q4 2024 stood at 0.38%, up from 0.81% in the prior quarter.
  • The five-year high for Tax Rate was 1.53% in Q2 2020, with the low at 3.85% in Q3 2023.
  • Average Tax Rate over 3 years is 0.12%, with a median of 0.57% recorded in 2020.
  • Peak annual rise in Tax Rate reached 764 bps in 2020, while the deepest fall reached 38 bps in 2020.
  • Tracing CCCC's Tax Rate over 3 years: stood at 0.57% in 2020, then slumped by 244 bps to 0.81% in 2023, then jumped by 53 bps to 0.38% in 2024.
  • The last three Tax Rate figures came in at 0.38% (Q4 2024), 0.81% (Q4 2023), and 3.85% (Q3 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 57.14
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 5.61
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 17.68
7 Evaxion A 62.56 Bn 62.54 Bn - -6.79
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 12.51
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 7.07
10 C4 Therapeutics 561.03 Mn 325.36 Mn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 -0.38
Dec 31, 2024 -0.38
Dec 31, 2023 -0.81
Dec 31, 2023 -0.81
Sep 30, 2023 -3.85
Sep 30, 2023 -3.85
Dec 31, 2020 0.57
Dec 31, 2020 0.57
Sep 30, 2020 0.76
Sep 30, 2020 0.76
Jun 30, 2020 1.53
Jun 30, 2020 1.53
Mar 31, 2020 1.38
Mar 31, 2020 1.38
Dec 31, 2019 0.95
Dec 31, 2019 0.95
Sep 30, 2019 -6.88
Sep 30, 2019 -6.88